203 related articles for article (PubMed ID: 20412876)
21. A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.
Bernstein DI; Pasetti MF; Brady R; Buskirk AD; Wahid R; Dickey M; Cohen M; Baughman H; El-Khorazaty J; Maier N; Sztein MB; Baqar S; Bourgeois AL
Vaccine; 2019 Jan; 37(4):602-611. PubMed ID: 30563789
[TBL] [Abstract][Full Text] [Related]
22. Mucosal immunization of BALB/c mice using enterotoxigenic Escherichia coli colonization factors CFA/I and CS6 administered with and without a mutant heat-labile enterotoxin.
Byrd W; Cassels FJ
Vaccine; 2003 May; 21(17-18):1884-93. PubMed ID: 12706673
[TBL] [Abstract][Full Text] [Related]
23. Comparison of immune responses in parenteral FaeG DNA primed pigs boosted orally with F4 protein or reimmunized with the DNA vaccine.
Melkebeek V; Verdonck F; Goddeeris BM; Cox E
Vet Immunol Immunopathol; 2007 Apr; 116(3-4):199-214. PubMed ID: 17331591
[TBL] [Abstract][Full Text] [Related]
24. The mucosal adjuvanticity of two nontoxic mutants of Escherichia coli heat-labile enterotoxin varies with immunization routes.
Park EJ; Chang JH; Kim JS; Yum JS; Chung SI
Exp Mol Med; 2000 Jun; 32(2):72-8. PubMed ID: 10926118
[TBL] [Abstract][Full Text] [Related]
25. Genetically detoxified mutants of heat-labile enterotoxin from Escherichia coli are effective adjuvants for induction of cytotoxic T-cell responses against HIV-1 gag-p55.
Neidleman JA; Vajdy M; Ugozzoli M; Ott G; O'Hagan D
Immunology; 2000 Sep; 101(1):154-60. PubMed ID: 11012767
[TBL] [Abstract][Full Text] [Related]
26. Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates.
VanCott JL; Prada AE; McNeal MM; Stone SC; Basu M; Huffer B; Smiley KL; Shao M; Bean JA; Clements JD; Choi AH; Ward RL
J Virol; 2006 May; 80(10):4949-61. PubMed ID: 16641286
[TBL] [Abstract][Full Text] [Related]
27. CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G).
McNeal MM; VanCott JL; Choi AH; Basu M; Flint JA; Stone SC; Clements JD; Ward RL
J Virol; 2002 Jan; 76(2):560-8. PubMed ID: 11752147
[TBL] [Abstract][Full Text] [Related]
28. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants.
Scharton-Kersten T; Yu Jm; Vassell R; O'Hagan D; Alving CR; Glenn GM
Infect Immun; 2000 Sep; 68(9):5306-13. PubMed ID: 10948159
[TBL] [Abstract][Full Text] [Related]
29. Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin.
Caputo A; Brocca-Cofano E; Castaldello A; Voltan R; Gavioli R; Srivastava IK; Barnett SW; Cafaro A; Ensoli B
Vaccine; 2008 Feb; 26(9):1214-27. PubMed ID: 18243435
[TBL] [Abstract][Full Text] [Related]
30. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.
Verweij WR; de Haan L; Holtrop M; Agsteribbe E; Brands R; van Scharrenburg GJ; Wilschut J
Vaccine; 1998 Dec; 16(20):2069-76. PubMed ID: 9796066
[TBL] [Abstract][Full Text] [Related]
31. Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants.
Nawar HF; Arce S; Russell MW; Connell TD
Infect Immun; 2007 Feb; 75(2):621-33. PubMed ID: 17118982
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice.
Maciel M; Smith M; Poole ST; Laird RM; Rollenhagen JE; Kaminski RW; Wenzel H; Bourgeois AL; Savarino SJ
PLoS One; 2019; 14(11):e0224073. PubMed ID: 31682624
[TBL] [Abstract][Full Text] [Related]
33. Humoral and cellular immune responses in the murine respiratory tract following oral immunization with cholera toxin or Escherichia coli heat-labile enterotoxin.
Ruedl C; Rieser C; Kofler N; Wick G; Wolf H
Vaccine; 1996 Jun; 14(8):792-8. PubMed ID: 8817827
[TBL] [Abstract][Full Text] [Related]
34. The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT).
Cheng E; Cárdenas-Freytag L; Clements JD
Vaccine; 1999 Aug; 18(1-2):38-49. PubMed ID: 10501233
[TBL] [Abstract][Full Text] [Related]
35. Distinctive immunomodulatory and inflammatory properties of the Escherichia coli type II heat-labile enterotoxin LT-IIa and its B pentamer following intradermal administration.
Mathias-Santos C; Rodrigues JF; Sbrogio-Almeida ME; Connell TD; Ferreira LC
Clin Vaccine Immunol; 2011 Aug; 18(8):1243-51. PubMed ID: 21677110
[TBL] [Abstract][Full Text] [Related]
36. Determining the activity of mucosal adjuvants.
Baudner BC; Giudice GD
Methods Mol Biol; 2010; 626():261-85. PubMed ID: 20099134
[TBL] [Abstract][Full Text] [Related]
37. Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers.
Stephenson I; Zambon MC; Rudin A; Colegate A; Podda A; Bugarini R; Del Giudice G; Minutello A; Bonnington S; Holmgren J; Mills KH; Nicholson KG
J Virol; 2006 May; 80(10):4962-70. PubMed ID: 16641287
[TBL] [Abstract][Full Text] [Related]
38. Different profile and distribution of antigen specific T cells induced by intranasal and intrarectal immunization with rotavirus 2/6-VLP with and without LT-R192G.
Alkadah A; Thiam F; Mounier M; Charpilienne A; Poncet D; Kohli E; Basset C
Vaccine; 2013 Apr; 31(15):1924-30. PubMed ID: 23453731
[TBL] [Abstract][Full Text] [Related]
39. Heat-labile enterotoxin of Escherichia coli and its site-directed mutant LTK63 enhance the proliferative and cytotoxic T-cell responses to intranasally co-immunized synthetic peptides.
Partidos CD; Salani BF; Pizza M; Rappuoli R
Immunol Lett; 1999 Apr; 67(3):209-16. PubMed ID: 10369128
[TBL] [Abstract][Full Text] [Related]
40. The ocular conjunctiva as a mucosal immunization route: a profile of the immune response to the model antigen tetanus toxoid.
Barisani-Asenbauer T; Inic-Kanada A; Belij S; Marinkovic E; Stojicevic I; Montanaro J; Stein E; Bintner N; Stojanovic M
PLoS One; 2013; 8(4):e60682. PubMed ID: 23637758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
